SHL announces appointment of Mr. Yariv Alroy as chairman of the Board of Directors Donnerstag, 13. Dezember 2018 - 17:35

Press release

SHL announces appointment of Mr. Yariv Alroy as chairman of the Board of Directors

Tel Aviv / Zurich, December 13, 2018 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) (“SHL”), a leading provider and developer of advanced personal telemedicine solutions announced today that Mr. Yariv Alroy was unanimously elected today by the Board of Directors to serve as the Chairman of the Board. Mr. Alroy has served as SHL’s co-CEO between the years 2000-2016. For a CV of Mr. Yariv Alroy please refer to SHL’s website at http://www.shl-telemedicine.com/about-us/board-of-directors/.

For further information please contact:

Martin Meier-Pfister, IRF Communications, Phone: +41 43 244 81 40, shl@irfcom.ch

About SHL Telemedicine

SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957). For more information, please visit the web site at www.shl-telemedicine.com.

Some of the information contained in this press release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. SHL Telemedicine undertakes no obligation to publicly update or revise any forward-looking statements.